Home
miR Scientific

miR Scientific Market Share Analysis for May 2026

MiRNA’s Disease Management Platform™ gives providers and patients first-time access to actionable health data, illuminating a clear path to cancer management.

Industry: N/A

Domainmirscientific.com

Year Founded2013

Employees51 - 200

Annual Revenue$2M - $5M

miR Scientific

miR Scientific (including company regionals)

mirscientific.com

See more website traffic and engagement information

miR Scientific Revenue up to May 2026 is 2M - 5M

revenue generated by miR Scientific top domains

miR Scientific top domains revenue over 3 years

Revenue for miR Scientific top domains

mirscientific.com2M - 5M

See more with Sales Intelligence

Total visits to miR Scientific's top domains

Understand miR Scientific market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in miR Scientific's top domains

Analyze miR Scientific engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on miR Scientific's top domains

See how miR Scientific keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

miR Scientific top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by miR Scientific

These are the website technologies, by industry, used by miR Scientific top domains

Payment & Currencies (6)

Cart Functionality

Widget (4)

reCAPTCHA

Content Management System (2)

WordPress

Email Services (2)

Microsoft Exchange Online

More Technologies

12

See all

News & Signals from miR Scientific

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMirscientific launched miR Sentinel Prostate Cancer Test on Jul 13th '22.miR Scientific, LLC announces the miR Sentinel Prostate Cancer Test is now commercially available in the United States, Puerto Rico and select international markets.

NewsMirscientific launches FDA Breakthrough Device Designation for Prostate Cancer Liquid Biopsy Test.miR Scientific announces FDA Breakthrough Device Designation for its Prostate Cancer Liquid Biopsy Test.

NewsMirscientific hires James 'Jim' Roosevelt, Jr. as Advisory Board Member.miR Scientific, LLC announces the appointment of James 'Jim' Roosevelt, Jr., a senior executive in health plan leadership and healthcare policy, as Advisory Board Member.